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Background: The arylamine N-acetyltransferases (NATs) are a unique family of enzymes widely distributed in nature
that play a crucial role in the detoxification of aromatic amine xenobiotics. Considering the temporal changes in
the levels and toxicity of environmentally available chemicals, the metabolic function of NATs is likely to be under
adaptive evolution to broaden or change substrate specificity over time, making NATs a promising subject for
evolutionary analyses. In this study, we trace the molecular evolutionary history of the NAT gene family during the
last ~450 million years of vertebrate evolution and define the likely role of gene duplication, gene conversion and
positive selection in the evolutionary dynamics of this family.
Results: A phylogenetic analysis of 77 NAT sequences from 38 vertebrate species retrieved from public genomic
databases shows that NATs are phylogenetically unstable genes, characterized by frequent gene duplications and
losses even among closely related species, and that concerted evolution only played a minor role in the patterns of
sequence divergence. Local signals of positive selection are detected in several lineages, probably reflecting
response to changes in xenobiotic exposure. We then put a special emphasis on the study of the last ~85 million
years of primate NAT evolution by determining the NAT homologous sequences in 13 additional primate species.
Our phylogenetic analysis supports the view that the three human NAT genes emerged from a first duplication
event in the common ancestor of Simiiformes, yielding NAT1 and an ancestral NAT gene which in turn, duplicated
in the common ancestor of Catarrhini, giving rise to NAT2 and the NATP pseudogene. Our analysis suggests a main
role of purifying selection in NAT1 protein evolution, whereas NAT2 was predicted to mostly evolve under positive
selection to change its amino acid sequence over time. These findings are consistent with a differential role of the
two human isoenzymes and support the involvement of NAT1 in endogenous metabolic pathways.
Conclusions: This study provides unequivocal evidence that the NAT gene family has evolved under a dynamic
process of birth-and-death evolution in vertebrates, consistent with previous observations made in fungi.
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Arylamine N-acetyltransferases (NATs) are xenobiotic me-
tabolizing enzymes found in a wide range of species across
all major clades of life (bacteria, archaea, eukaryotes), ex-
cept plants [1-3]. This unique family of enzymes catalyses
the transfer of an acetyl group from acetyl-coenzyme A
(acetyl-CoA) to the terminal nitrogen of arylamine, hydra-
zine and heterocyclic amine compounds. Biochemical,
structural and functional studies of the last decades have
increased our understanding of the potentially diverse
roles of NATs in endogenous and xenobiotic metabolism,
establishing their key role in cellular homeostasis as well
as in gene-environment interactions [4-6].
Humans have two functional NAT genes (NAT1 and
NAT2) and one pseudogene (NATP), located within 200 ki-
lobases (kb) on chromosome 8 [7,8]. Both NAT1 and
NAT2 genes have intronless coding regions with a single
coding exon of 870 base pairs (bp) that produces a 290
amino acid (34 kDa) protein. They share 81% nucleotide
identity, which translates to 87% identity at the amino acid
level. The pseudogene NATP displays high sequence iden-
tity to NAT1 and NAT2 (79%) but contains multiple frame-
shift and premature stop codon mutations leading to loss
of function [9]. Despite their high degree of sequence iden-
tity, NAT1 and NAT2 encode isoenzymes with distinct sub-
strate specificities, tissue distribution and expression levels
during development. NAT1 is widely expressed in most tis-
sues and cell types and preferentially acetylates substrates
such as p-aminobenzoic acid (pABA), p-aminosalicylic acid
(pASA) and p-aminobenzoylglutamate (pABG). NAT2 has
a more restricted expression profile, being predominantly
expressed in the liver, small intestine and colon, and prefers
bulkier substrates such as sulphamethazine, isoniazid,
procainamide, and dapsone (reviewed in [10]). The wide-
spread tissue distribution of NAT1, its selectivity for pABG
as well as its early expression in development (as early as
the blastocyst stage [11]), have suggested that NAT1 may
have an endogenous role in addition to the metabolism of
xenobiotics. Acetylating the folate breakdown product
pABG is now generally accepted to be an endogenous role
of this enzyme which might be important in normal em-
bryonic development [12,13]. The importance of NAT1
and NAT2 in the metabolism of drugs and in the activation
of common environmental carcinogens has led to a pleth-
ora of molecular epidemiological studies that have shown
associations of NAT gene polymorphisms with individual
drug response and susceptibility to cancers linked to
arylamine exposure [14-16].
Because of their role in the detoxification of exogenous
chemicals present in the diet and the environment, hu-
man NAT1 and NAT2 genes have long been considered
as likely targets of population-specific selective pres-
sures, a hypothesis further fuelled by the intriguing pat-
terns of geographic differentiation of their major alleles[17-24]. In particular, the NAT2 gene, which exhibits a
well established acetylation polymorphism leading to a
phenotype classification of individuals into rapid and
slow acetylators, has been the subject of numerous stud-
ies examining its nucleotide sequence variation in a wide
range of ethnically diverse populations and determining
the role of natural selection in shaping genetic variation
at this locus. Several surveys provided clear evidence for
a correlation between the prevalence of slow acetylators
in human populations and the subsistence strategy
adopted by their ancestors in the last 10,000 years,
suggesting that a slower rate of acetylation may have
provided a selective advantage in populations shifting
from foraging to pastoralism/agriculturalism in the Neo-
lithic period [18,20,21,24]. It is thus currently held that
the Neolithic transition triggered significant changes in
dietary exposure to environmental chemicals that modi-
fied the selective regime affecting the NAT2 acetylation
pathway. Likewise, and more generally, considering the
temporal fluctuations in the kinds and levels of environ-
mentally available xenobiotic compounds over evolu-
tionary time, the metabolic function of NATs is likely to
be under adaptive evolution and the NAT genes could be
broadening or changing substrate specificity in response
to changing environmental conditions. Yet, in contrast
to the numerous population genetic studies carried out
for human polymorphic NAT genes, no study to date has
investigated the role of positive selection in the expan-
sion and functional diversification of the NAT genetic
loci at a deeper evolutionary time scale.
The aim of the present work was to thoroughly exam-
ine the molecular evolutionary history of the NAT gene
family during the last ~450 million years. A phylogenetic
analysis of 77 NAT homologous nucleotide sequences
from 38 vertebrate species retrieved from genomic data-
bases was used to determine the likely contribution of
gene duplication, gene conversion and positive selection
to the evolutionary dynamics of this family. A special
emphasis was put on the study of the last ~85 million
years of primate NAT evolution by determining the NAT
coding sequences in 13 additional primate species. The
results of this work greatly improved our understanding
of the evolutionary regime that has shaped the NAT
protein-coding sequence: it allowed us to clarify the par-
alogous and orthologous relationships among the NAT
genes in vertebrate species, date the gene-duplication
events giving rise to the human NAT gene family, and
identify episodes of adaptive evolution at specific sites
and domains of the protein.
Results
Phylogenetic analysis of vertebrate NAT sequences
To study the molecular evolution of the NAT gene family
in vertebrates, we retrieved all available NAT-homologous
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dataset of 77 NAT coding sequences from 38 species
representing all major vertebrate taxa (‘vertebrate dataset’).
These 77 sequences included 68 full-length open reading
frames (ORFs) with sizes ranging from 864 to 870 bp and
9 partial coding sequences containing 15 to 166 missing
nucleotides. In most species, we identified one or two dis-
tinct NAT sequences but in some others, up to five func-
tional NAT genes were found (7, 2 and 1 species harbored
3, 4 and 5 distinct sequences, respectively). A second NAT
sequence was identified in Dipodomys ordii and Vicugna
pacos but the corresponding ORFs were missing 300 and
500 nucleotides, respectively, so they were not included in
the final dataset. No NAT-like sequences were found in
the current assembly of the dog genome (CanFam2.0),
confirming the previous findings of Trepanier and col-
leagues [25] who were unable to detect NAT homologues
in any of 25 domestic dogs and 8 wild canids studied. The
proportion of sequence identity to human NAT1 varied
from 51.2% (Danio rerio NAT4) to 98.9% (Gorilla gorilla
NAT1) at the nucleotide level. The alignment result of the
77 nucleotide sequences is provided in Additional file 1.
Three sequences showed a 3-bp insertion at positions
385–387 resulting in an additional amino acid in the pro-
tein (either a phenylalanine in Ornithorhynchus anatinus
NAT1 or a proline in Gallus gallus NAT2 and Meleagris
gallopavo NAT2), while eleven sequences from seven spe-
cies carried a deletion of either 3, 6 or 9 bp, resulting in a
loss of either 1, 2 or 3 contiguous amino acids. In all se-
quences, the three residues composing the ‘Cys-His-Asp’
catalytic triad (Cys68, His107, Asp122), which is essential
to the NAT enzymatic activity, were conserved, indicating
that the encoded enzymes are likely to be functional.
A maximum-likelihood (ML) phylogeny was constructed
with PhyML using the NAT coding nucleotide alignment
(Figure 1). This phylogeny was largely congruent with the
currently accepted phylogeny of vertebrate species at the
class (Mammalia, Aves, Reptilia, Actinopterygii) and order
(Primates, Rodentia, Lagomorpha, Carnivora, etc.) levels.
In most species carrying more than one functional NAT
gene, the paralogs were more similar to each other than
the corresponding orthologs, suggesting multiple species-
specific gene duplication events. One exception concerns
the sequences of the mouse and rat species which cluster
into three paralog groups Nat1, Nat2 and Nat3, suggesting
that the three genes were present before the divergence of
the two rodent species. This may also be the case for the
Syrian and Chinese hamsters (Mesocricetus auratus and
Cricetulus griseus, respectively), whose genomes have not
been sequenced yet and which may harbor three functional
genes as well. Another exception involves the catarrhine
species (human, chimpanzee, gorilla, orangutan, macaque
and baboon) where a single duplication event probably oc-
curred in the common ancestor of these species giving riseto the human NAT1 and NAT2 homologous genes. The
tree also suggests that two duplication events prior to the
divergence of species also occurred in the Aves clade. Be-
sides these exceptions, our phylogenetic analysis indicates
that lineage- and species-specific gene duplications are
widespread in the evolutionary history of the NAT gene
family, so that most NAT genes in vertebrates are the prod-
ucts of recent gene duplication events.
However, some aspects of the sequence divergence pat-
terns observed in the tree might also be attributed to con-
certed evolution via interparalog gene conversion which
homogenizes the sequences of different members of a gene
family within a genome. This would explain why different
NAT paralogs within a species (e.g., Cavia porcellus,
Pteropus vampyrus, Myotis lucifugus, Procavia capensis,
Loxodonta africana, Danio rerio, etc.) cluster together in
the tree. To detect and characterize putative recombination
events among NAT genes, we used six different methods
designed to pinpoint recombination break-points and de-
fine gene conversion tracts (see Methods). By combining
the results of all six methods, a total of eight recombination
events were detected affecting seven NAT paralog pairs in
seven species (Table 1); only four of them were detected by
at least two different algorithms. In view of the inferred
phylogenetic relationships amongNAT sequences (Figure 1),
the detected conversion events could explain the preferen-
tial clustering of NAT paralogs in the Danio rerio, Oryzias
latipes, Echinops telfairi and Myotis lucifugus species. How-
ever, when removing all the regions affected by gene con-
version from the nucleotide alignment (considering the
eight detected conversion events with the largest boundar-
ies), exactly the same topology was obtained in the resulting
tree (Additional file 2: Figure S1), with nearly identical
bootstrap values (except for an increased statistical support
of the clustering of Oryzias latipes NAT2 with the NAT1
and NAT2 sequences from Gasterosteus aculeatus; boot-
strap value = 909/1000, Additional file 2: Figure S1, instead
of 574/1000, Figure 1). This suggests that gene conversion
is unlikely to have confounded the analysis and that con-
certed evolution has only played a minor role (if any) in the
patterns of divergence of NAT sequences in vertebrates.
Overall, our results indicate that the NAT gene family has
undergone rapid evolution with frequent gene duplications
and losses (birth-and-death evolution) throughout verte-
brate evolution even among closely related species.
This scenario is further supported by the fine-scale syn-
teny data retrieved for several vertebrate species in an ex-
tended region encompassing the NAT genes locus. The
dynamic pattern of gene duplication and loss is robustly
apparent in comparing the human and mouse genomes,
which are especially mature in sequence and annotation
(Additional file 3: Figure S2). Although both the human
and mouse NAT clusters are composed of three loci lo-
cated in homologous regions of chromosome 8 (two
Figure 1 Phylogenetic tree of the NAT gene family based on 77 vertebrate nucleotide sequences. Shown is the maximum likelihood tree
built using PhyML (GTR + I + G) and rooted with the three fish species (Danio rerio, Gasterosteus aculeatus, Oryzias latipes). The bootstrap values of
1,000 replicates are shown as percentages at nodes. Bootstrap values are only shown for nodes with greater than 50% support. The clades of
Afrotheria, Laurasiatheria, Lagomorpha, Rodentia and Primates are shown in aqua blue, purple, green, blue and red, respectively.
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functional genes in mouse), no one-to-one ortholog rela-
tionships could be defined because of the presence of a
predicted pseudogene not related to NAT sequences be-
tween the mouse Nat2 and Nat3 genes and the total loss
of shared synteny on the telomeric side of the clusters.
Combined with the phylogenetic relationships inferred in
the ML tree (Figure 1), these data rather support a sce-
nario where the human and mouse syntenic gene clusters
have originated from a shared ancestral gene or genes,
with repeated local gene duplications and losses giving rise
to lineage-specific groups of related genes (rodents and
primates in the present case). As a further illustration, the
genomic sequences of the three bird species studied weresimilarly compared (Figure 2). An extended region of con-
served fine-scale synteny encompasses the chicken (Gallus
gallus), turkey (Meleagris gallopavo) and zebra finch
(Taeniopygia guttata) NAT genes, confirming that the
NAT paralogs of these species share a common genomic
history. Both the chromosomal location and patterns of
clustering of avian NAT sequences support the existence
of three NAT genes (corresponding to the NAT1, NAT2
and NAT3/4/5 clusters of genes in the ML tree) before the
split of the three bird species. Thus, the three paralogous
NAT1, NAT2 and NAT3 sequences within each species
likely result from the same tandem gene duplication
events occurring in the common ancestor to these species.
While no further gene duplication event apparently
Table 1 Significant recombination events detected among NAT genes using six different methods
Species Genes 5' breakpointa 3' breakpointa Length (bp)a P-value rangeb Methodsb
Rattus norvegicus NAT1 : NAT2 382/385/401 609/611 209/225/230 9.06 E-3–1.00 E-6 GeneConv, RDP, MaxChi, Chimaera,
Bootscan, SiScan
Oryzias latipes NAT1 : NAT2 1 260/262 260/262 8.87 E-3–6.39 E-6 Geneconv, RDP, MaxChi, Chimaera,
Bootscan
Echinops telfairi NAT1 : NAT2 43 642 600 1.00 E-4 Geneconv
Myotis lucifugus NAT1 : NAT2 600/615 742/749 128/150 6.06 E-4–1.39 E-4 MaxChi, Chimaera,
Mus musculus NAT1 : NAT2 382 518 137 2.00 E-4 Geneconv
Mesocricetus auratus NAT1 : NAT2 1 155/163/167 155/163/167 9.32 E-3–2.93 E-4 RDP, Chimaera, Bootscan, SiScan
Myotis lucifugus NAT1 : NAT2 1 204 204 3.00 E-4 Geneconv
Danio rerio NAT2 : NAT3 88 507 420 7.90 E-3 Geneconv
a Breakpoint positions refer to the nt positions in the full alignment of the vertebrate NAT sequences. They may slightly vary depending on the method used to
detect recombinant sequences, leading to different gene conversion tract lengths.
b In cases where multiple methods detected the same or a similar conversion event, we reported the P-value range, i.e. the worst and the best P-value; the
method yielding the best P-value is shown in bold. Otherwise, only the P-value of the single algorithm detecting a conversion event is presented.
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NAT3 sequences happened independently in the genomes
of chicken and zebra finch, giving rise to chicken NAT4
and zebra finch NAT4 and NAT5, respectively. These data
further demonstrate the complex history of duplications
of the NAT gene family, with many cases of recent gene
duplications occurring independently in specific lineages.
Maximum-likelihood analysis of selective pressures in
vertebrate NAT sequences
Since some aspects of NAT evolution are likely driven by
xenobiotic exposure, we investigated the possible role of
natural selection in the evolutionary history of this gene
family. To test for evidence of positive selection actingFigure 2 Gene order and orientation in regions surrounding NAT gen
gallopavo) chromosome 13 and zebra finch (Taeniopygia guttata) chro
drawn to scale. Grey boxes indicate NAT-like sequences. Black boxes repres
zebra finch. Double slashes (//) indicate continuing sequence data extendin
chromosome. In each species, NAT genes are arrayed linearly along a single
through tandem repeats, except in zebra finch where a fifth copy is found
17,484,630 in galGal3 assembly) represents a short sequence of 873 bp, ide
within the NAT3 gene (chr11:17,481,972-17,493,917) upstream of the NAT3 cat specific sites of the NAT coding region or along par-
ticular branches of the phylogenetic tree, a series of
nested likelihood ratio tests (LRTs) using different sets
of site-specific and branch-specific models were carried
out using the codeml program of the PAML package
[26] (Table 2). When applied to the DNA codon align-
ment of the full vertebrate dataset (n = 77 sequences),
LRTs of site-specific models indicated both varying ω
ratio among sites (M0 vs. M3: P < 0.0001) and positive
selection at a small subset of sites (M2a vs. M1a:
P = 0.0005; M8 vs. M7: P < 0.0001), indicating that the
NAT coding region has evolved under diversifying selec-
tion in vertebrates. Log-likelihood values showed that
M8 was the model that best fitted the data. This modeles on chicken (Gallus gallus) chromosome 11, turkey (Meleagris
mosomes 11 and Un. Gene lengths and intergenic distances are not
ent chicken-specific genes with no homologous sequences in turkey or
g toward the centromeric (cen) and telomeric (tel) parts of the
chromosome, indicating an expansion of the NAT gene family
on an unidentified (Un) chromosome. Chicken NAT4 (chr11:17,483,758-
ntical to the NAT3 protein-coding sequence, which is embedded
oding sequence.
Table 2 Results of PAML analyses for the vertebrate dataset
Data set 2ΔlnL df P-value Proportion of sites with ω > 1
(average ω for these sites)
Positively selected codonsa
All vertebrates (n = 77)
M1a vs. M2a 15.22 2 P = 0.0005 0.017 (ω = 2.0)
M7 vs. M8 34.89 2 P < 0.0001 0.050 (ω = 1.3) 97**, 98*, 104*, 286*
M0 vs. free ratios 510.67 142 P < 0.0001
Mammals (n = 55)
M1a vs. M2a 31.27 2 P < 0.0001 0.027 (ω = 2.3)
M7 vs. M8 47.39 2 P < 0.0001 0.066 (ω = 1.6) 97**, 98*, 104*, 214*, 286**
M0 vs. free ratios 265.71 100 P < 0.0001
Primates (n = 17)
M1a vs. M2a 0 2 P = 1.0 none
M7 vs. M8 0 2 P = 1.0 none
M0 vs. free ratios 36.45 28 P = 0.13
n, number of sequences; 2ΔlnL, twice the log-likelihood difference of the models compared; df, degrees of freedom; P-value, level of significance (P-values < 0.05 are
shown in bold).
a Sites pinpointed to be under positive selection under the selection model with the highest likelihood (M8 for the vertebrate and mammalian datasets) by Bayes
Empirical Bayes (BEB) analysis. Only sites with posterior probability greater than 0.95 (*) or 0.99 (**) are shown. Sites are numbered according to the full human
coding sequence.
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with an average estimated ω ratio of 1.3. The Bayes empir-
ical Bayes (BEB) analysis identified four sites under posi-
tive selection with high posterior probabilities (PP) under
M8 (PP ≥ 95%): residues 97, 98, 104, and 286, the first
three of which are involved in acetyl-CoA (cofactor) bind-
ing [27,28]. Likewise, the free-ratio model implemented in
PAML, which allows an independent assignment of ω ra-
tios to each evolutionary branch, gave a significantly better
fit to the data than the one-ratio model M0, thus
suggesting lineage-specificity of ω (P < 0.0001; Table 2).
Out of the 143 branches of the analyzed phylogeny, 18
branches (i.e. 12.6%) showed evidence of positive selection
(ω >1; Figure 3), with the highest ω values for branches d,
e, k, n, o, and p (ω ratios ranging from 6.3 to ∞). Interest-
ingly, four branches with evidence of positive selection
clustered in the Pteropus vampyrus NATs clade (branches
i, j, k and l). Detailed analysis of the patterns of nucleotide
substitutions along the four branches leading to the three
paralogous NAT sequences found in this bat species re-
vealed a striking pattern of accelerated amino acid evolu-
tion due to positive selection: as many as 39 different
nonsynonymous changes affecting the NAT protein-
coding sequence occurred within this single clade
(Additional file 4: Table S1). It is noteworthy that nearly
half (18/39) of these nonsynonymous changes are located
either in the interdomain region of the protein, which con-
tains several residues involved in substrate and cofactor
binding (codons 204 to 220), or in the C-terminal region,
which has a major role in arylamine substrate specificity
(codons 267 to 286) [27,29]. Given that positive selection
often operates only on a few amino acid sites alongparticular branches, we employed branch-site models (see
Methods) to detect whether some sites along particular
branches of the phylogeny are under positive selection.
Since the subset of branches to be tested has to be speci-
fied a priori and independently of the results of the
branch-specific test, we decided to focus on those branches
defining the major taxonomic groups of the vertebrate
phylogeny, numbered from B1 to B13 (Figure 3). Four of
these branches, leading to fishes (B1, P = 0.0002), avian
NAT2/NAT3/NAT4/NAT5 sequences (B4, P = 0.0015),
mammals (B5, P = 0.049) and rodents (B12, P = 0.048),
showed evidence of positive selection at the non-corrected
threshold of 0.05. Only the two formers remained signifi-
cant after correction for multiple testing. Two sites
were identified by the BEB analysis as positively se-
lected (PP ≥ 95%): codon 11 (PP = 0.958) along the
lineage leading to avian NAT2/NAT3/NAT4/NAT5 se-
quences and codon 272 (PP = 0.957) along the lineage
leading to rodents. When branch-site tests were
performed at the clade level (C1 to C13), only lizard
sequences provided significant results (C2, P = 0.0004),
which persisted after correction for multiple testing.
In this clade, two codons were identified as positively
selected: 100 (PP = 0.960) and 102 (PP = 0.964). Note
that the four sites identified by the branch-site tests
(11, 272, 100 and 102) are in addition to those identi-
fied with site-specific models.
When restricting the analysis to the 55 mammalian se-
quences of the vertebrate data set, similar results were
obtained. Model M8 provided the best fit to the data
with 6.6% of sites having a positive ω of 1.6 (Table 2).










































Figure 3 Evidence for lineage-specific positive selection in the vertebrate NAT phylogeny. The branches with ω ratios > 1, as estimated by the
free-ratio model (branch-specific test), are shown with black thick lines and are labeled from a to r. The estimated ω ratio and numbers of nonsynonymous
and synonymous changes for each branch are as follows: a (1.26; 56.5/16.3), b (1.76; 22.8/4.7), c (1.07; 6.2/2.1), d (∞; 8.1/0.0), e (231.27; 45.7/0.1), f (1.07; 43.8/
15.0), g (1.07; 3.3/1.1), h (1.11; 6.7/2.2), i (2.85; 10.7/1.4), j (2.54; 14.0/2.0), k (∞; 4.9/0.0), l (2.43; 13.4/2.0), m (1.41; 9.2/2.4), n (∞; 8.2/0.0), o (6.31; 12.0/0.7), p (∞; 5.1/
0.0), q (1.11; 3.1/1.0), r (1.56; 4.5/1.1). In addition, branch-site tests were carried out to test for positive selection in 13 pre-specified lineages (highlighted in red):
the ‘B’ letter refers to the branch-site tests performed at the branch level and the ‘C’ letter refers to those performed at the clade level (multiple branch-site
analysis, see Methods). We focused on the major taxonomic groups of the vertebrate phylogeny: Primates (#13), Rodentia (#12), Lagomorpha (#11), Glires
(Rodentia + Lagomorpha, #10), Euarchontoglires (Primates +Glires, #9), Laurasiatheria (#8), Afrotheria (#7), Eutheria (#6), Mammalia (#5), Sauropsida (#2), and the
fish species (#1). As the group of avian NAT sequences was not monophyletic, we separately tested the subgroup of NAT1 sequences and the subgroup of
NAT2/NAT3/NAT4/NAT5 sequences in birds (#3 and #4, respectively). * Statistically significant branch-site tests at the conventional P-value threshold of 0.05
(not corrected for multiple testing). ** Statistically significant branch-site tests at the Bonferroni-corrected threshold of 0.0038 (13 tests).
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in the acetyl-CoA binding pocket (codon 214). However,
when the analysis was restricted to the 17 primate se-
quences, no significant evidence of positive selection
was detected (P > 0.05), neither at the site nor at the
branch level. This suggests either that the selective pres-
sure that recurrently drove positive selection of verte-
brate NATs became relaxed in the primate lineage, or
that the statistical power provided by the small number
of sequences available for analysis may be insufficient to
get significant results when performing the LRT tests
implemented in PAML. These tests have indeed been
shown to lack power when data contain only few num-
bers of slightly divergent sequences [30]. In such a case,
sampling a larger number of lineages is considered as
the best way to improve the accuracy and power of LRTs
and has been shown to cause a spectacular rise in power,
even when sequence divergence is low [30,31]. There-
fore, we sought to gain power by determining the NAT
coding sequences in 13 additional primate species,
bringing up to 22 the number of species available for
analysis in the primate clade.
NAT sequence evolution and analysis of selective
pressures in the primate lineage
A more thorough investigation of the evolutionary his-
tory of the NAT gene family was conducted in primates
by extending the analysis to 13 additional primate spe-
cies (including 3 hominoids, 8 Old World and 2 New
World monkeys) in which NAT nucleotide sequences
were determined for the first time. Two functional NAT
genes were found in all 13 species, whereas a third NAT
sequence, abolished by frameshift mutations and highly
similar to the human pseudogene NATP, was found in
ten of them. In all, the full primate data set comprised
59 nucleotide sequences from 22 primate species, in-
cluding 17 database sequences and 42 newly generated
ones. Whereas functional sequences were all of the same
length (a full NAT ORF of 870 bp), pseudogene se-
quences displayed considerable length variation due to
the significant number of indels disrupting NAT ORF
(ranging from 865 bp for Colobus guereza NATP to
881 bp for Gorilla gorilla NATP), resulting in a multiple
alignment of 890 sites (Additional file 5). These indels
involve both single and multiple nucleotides. All NATP
sequences have in common a single 1-bp deletion in
position 77, which is likely to be the first frameshift mu-
tation that occurred in the ancestral NATP coding
sequence.
The ML tree built using PhyML support monophy-
letic Strepsirrhini, Simiiformes (Anthropoidea), Platyrrhini,
Catarrhini, Cercopithecoidea and Hominidea clades
(Figure 4). In Simiiformes, NAT genes clearly cluster into
three paralog groups, all strongly supported (bootstrapvalues = 1000/1000) and regrouping sequences orthologous
to human NAT1, NAT2 and NATP. The paralog group of
NAT1 sequences displays the highest level of nucleotide
sequence identity (mean pairwise value 96.7%, range
93.2%–99.8%), followed by NAT2 (mean 95.1%, range
91.2%–100%) and NATP (mean 93.3%, range 89.7%–
98.9%). The accelerated evolution of the NATP pseudogene
is clearly apparent from the long branch leading to this
clade, probably reflecting relaxed purifying selection subse-
quent to the loss of protein functionality. Contrary to the
two functional genes, NATP sequences were obtained only
in catarrhine species. Hence, our phylogenetic analysis sug-
gests that the three human NAT genes emerged from a first
duplication event in the common ancestor of Simiiformes,
yielding NAT1 and an ancestral NAT gene which in turn,
duplicated in the common ancestor of Catarrhini, eventu-
ally giving rise to NAT2 and NATP. The absence of NATP
in one of the Hylobatidae species (Hylobates lar) can be
explained either by the loss of this gene (or of the primer
target regions) in this species or by a substantial divergence
of this sequence from its related orthologs, hampering its
effective amplification. Obviously, we cannot exclude the
possibility that similar reasons may explain the absence of
NATP in platyrrhine species. However, the high number of
trials performed (11 different primer pairs tested, arranged
on different parts of the gene including the 5’ and 3’ re-
gions, and varying PCR conditions) make this possibility
unlikely and rather support a true absence of the pseudo-
gene in Platyrrhini and Hylobates lar.
The phylogenetic analysis also demonstrates that NAT1
and NAT2 paralogs found in Microcebus murinus and
Tarsius syrichta are the result of independent gene dupli-
cation events that occurred after the divergence of these
species from the simian lineage and after the divergence of
Strepsirrhini and Tarsiiformes. Because no gene conver-
sion was detected with any of the six recombination detec-
tion methods for any pair of sequences in the primate
dataset, we can exclude concerted evolution as a possible
explanation for the greater similarity of NAT paralogs
within M. murinus and T. syrichta species. Otolemur
garnetti is the only primate species with a single NAT
gene identified. However, genomic coverage is still limited
(2-fold) for this species and we cannot exclude that add-
itional NAT copies may exist in its genome.
Next, we investigated the role of positive selection in
the evolution and diversification of the NAT gene family
in primates by applying PAML codon-based models to
the 43 coding sequences of the primate data set (16
pseudogene sequences excluded) (Table 3). Despite the
increased power afforded by the larger number of se-
quences included in the analysis (43 instead of 17 in the
initial analysis), we did not find any evidence of adaptive
selection during primate evolution at any NAT coding
site. Models M1a and M2a showed no difference (2ΔlnL
 Otolemur garnettii NAT1
 Microcebus murinus NAT2
 Microcebus murinus NAT1
 Tarsius syrichta NAT1
 Tarsius syrichta NAT2
 Cebus apella NAT1  
 Pithecia pithecia NAT1  
 Colobus guereza NAT1  
 Presbytis cristatus NAT1  
 Cercopithecus diana NAT1  
 Chlorocebus tantalus NAT1
 Erythrocebus patas NAT1 
 Allenopithecus nigroviridis NAT1
 Mandrillus sphinx NAT1  
 Papio hamadryas NAT1
 Macaca sylvanus NAT1   
 Macaca mulatta NAT1  
 Nomascus gabriellae NAT1  
 Hylobates lar NAT1  
 Pongo pygmaeus NAT1
 Pan troglodytes NAT1     
 Pan paniscus NAT1     
 Gorilla gorilla NAT1 
 Homo sapiens NAT1    
 Cebus apella NAT2  
 Pithecia pithecia NAT2  
 Colobus guereza NAT2  
 Presbytis cristatus NAT2  
 Allenopithecus nigroviridis NAT2
 Cercopithecus diana NAT2  
 Chlorocebus tantalus NAT2
 Erythrocebus patas NAT2 
 Mandrillus sphinx NAT2  
 Papio hamadryas NAT2
 Macaca sylvanus NAT2   
 Macaca mulatta NAT2  
 Nomascus gabriellae NAT2  
 Hylobates lar NAT2  
 Pongo pygmaeus NAT2
 Pan troglodytes NAT2     
 Pan paniscus NAT2 
 Gorilla gorilla NAT2 
 Homo sapiens NAT2    
 Colobus guereza NATP 
 Presbytis cristatus NATP  
 Allenopithecus nigroviridis NATP 
 Cercopithecus diana NATP  
 Chlorocebus tantalus NATP
 Erythrocebus patas NATP 
 Mandrillus sphinx NATP  
 Papio hamadryas NATP     
 Macaca sylvanus NATP   
 Macaca mulatta NATP 
 Nomascus gabriellae NATP
 Pongo pygmaeus NATP   
 Gorilla gorilla NATP  
 Pan troglodytes NATP  
 Pan paniscus NATP 
















































Figure 4 Phylogenetic tree of the NAT gene family in primates. Shown is the maximum likelihood tree built using PhyML (GTR + I + G) with
the multiple alignment of 59 NAT nucleotide sequences from 19 distinct primate species. The tree was rooted with the non simian species
(Otolemur garnetti, Microcebus murinus, Tarsius syrichta). The bootstrap values of 1,000 replicates are shown as percentages at nodes. Bootstrap
values are only shown for nodes with greater than 50% support. The clades of Strepsirrhini, Platyrrhini, Cercopithecidae, Hylobatidae and
Hominidae are shown in turquoise, green, blue, pink and red, respectively.
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Table 3 Results of PAML analyses for the primate dataset
Data set 2ΔlnL df P-value Proportion of sites with ω > 1
(average ω for these sites)
Positively selected codonsa
All NAT coding sequences (n = 43)
M1a vs. M2a 0 2 P = 1.0 none
M7 vs. M8 3.49 2 P = 0.17 none
M0 vs. free ratios 114.89 80 P = 0.006
Orthologous sequences to human NAT1 (n = 19)
M1a vs. M2a 0 2 P = 1.0 none
M7 vs. M8 0 2 P = 1.0 none
M0 vs. free ratios 49.09 34 P = 0.04
Orthologous sequences to human NAT2 (n = 19)
M1a vs. M2a 8.48 2 P = 0.01 0.038 (ω = 4.8)
M7 vs. M8 11.24 2 P = 0.004 0.041 (ω = 4.6) 191*, 173*
M0 vs. free ratios 27.52 34 P = 0.77
n, number of sequences; 2ΔlnL, twice the log-likelihood difference of the models compared; df, degrees of freedom; P-value, level of significance (P-values < 0.05 are
shown in bold).
a Sites pinpointed to be under positive selection under the selection model with the highest likelihood (M8 for the set of NAT2 orthologous sequences) by Bayes
Empirical Bayes (BEB) analysis. Only sites with posterior probability greater than 0.95 (*) or 0.99 (**) are shown. Sites are numbered according to the full human
coding sequence.
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than model M7 (2ΔlnL = 3.49, P > 0.05). Detailed analysis
of the tree using the free-ratio model of codeml did,
however, identify a number of branches with ω values
higher than 1.0, the strongest evidence being found in
the lineage leading to Strepsirrhini (branch a, Figure 5),
consistent with the full vertebrate dataset analysis re-
sults. The branch-site tests, performed at both the
branch and clade levels (Figure 5), identified one branch
evolving at an elevated rate compared to other branches
of the phylogeny (B1, P = 0.011) as well as three clades
within the set of orthologous NAT2 sequences with evi-
dence of positive selection (C7, P = 0.019; C8, P = 0.040;
C9, P = 0.017, C8 and C9 being component clades of
C7). These results were, however, no longer significant
after applying the Bonferroni correction for multiple
comparisons. No positively selected sites were identified
with significance (PP ≥ 95%) with these branch-site tests.
A possible limitation of our analysis is that it relies on
the assumption that the different orthologous and paralo-
gous sequences compared have equivalent functions. The
inclusion in the alignment of homologous proteins with
different biological functions which may have experienced
different selective regimes can indeed give rise to incorrect
estimations of ω. This could be the case if, as observed for
the human NAT1 and NAT2 paralogs, the two ancestral
NAT1 and NAT2 paralogs diverged in function soon after
the duplication event, before the first speciation leading to
Catarrhini and Platyrrhini. Thus, in order to maintain a
correct comparative framework and to avoid the inclusion
of paralogous sequences where changes in protein func-
tion occurred, we conducted separate analyses of the setsof orthologous NAT1 sequences and orthologous NAT2
sequences found in Simiiformes.
For the data set including the 19 sequences orthologous
to human NAT1, models incorporating positive selection
(M2a and M8) provided no better fit to the data than
models including only purifying selection and neutrally
evolving sites (M1a, M7) (Table 3). The null model M0,
which assumes only one ω for all amino acid sites, could
not be rejected (P > 0.05). Under this model, the estimate
of ω was 0.19, indicating that NAT1 sequences have been
subject to strong purifying selection to maintain protein
function over time. The selective regime has been variable
among species since different ω values along different
branches were significantly different from each other
(P = 0.04). Interestingly, despite the dominant role of puri-
fying selection in NAT1 protein evolution, a recent episode
of positive selection was detected specifically and exclu-
sively in the human lineage (branch b with ω =∞; Figure 5).
Five codon sites were found to show nonsynonymous sub-
stitutions along this branch (E46D, I149V, E195K, A214S,
E276Q), whereas no synonymous codon changes occurred.
By contrast, site-specific codeml analysis performed on
the set of sequences orthologous to human NAT2 yielded
very different results with a rather strong evidence of posi-
tive selection (M2a vs. M1a: P = 0.01; M8 vs. M7: P < 0.004,
Table 3), indicating that NAT2 has been subject to di-
versifying selection to change its amino acid sequence over
time (Table 3). Parameter estimates under model M8,
which provided the best fit to the data, suggested 4.1% of
sites to be under positive selection with ω = 4.6. Estimates
from posterior probability provided significant support of
positive selection for codons 173 and 191 (PP ≥ 95%)
 Otolemur garnettii NAT1
 Microcebus murinus NAT2
 Microcebus murinus NAT1
 Tarsius syrichta NAT2 
 Tarsius syrichta NAT1
 Cebus apella NAT1  
 Pithecia pithecia NAT1  
 Colobus guereza NAT1  
 Presbytis cristatus NAT1  
 Cercopithecus diana NAT1  
 Chlorocebus tantalus NAT1
 Erythrocebus patas NAT1 
 Allenopithecus nigroviridis NAT1
 Mandrillus sphinx NAT1  
 Papio hamadryas NAT1
 Macaca sylvanus NAT1   
 Macaca mulatta NAT1  
 Nomascus gabriellae NAT1  
 Hylobates lar NAT1  
 Pongo pygmaeus NAT1
 Pan troglodytes NAT1     
 Pan paniscus NAT1     
 Gorilla gorilla NAT1 
 Homo sapiens NAT1    
 Cebus apella NAT2  
 Pithecia pithecia NAT2  
 Colobus guereza NAT2  
 Presbytis cristatus NAT2  
 Allenopithecus nigroviridis NAT2
 Cercopithecus diana NAT2  
 Chlorocebus tantalus NAT2
 Erythrocebus patas NAT2 
 Mandrillus sphinx NAT2  
 Papio hamadryas NAT2
 Macaca sylvanus NAT2   
 Macaca mulatta NAT2  
 Nomascus gabriellae NAT2  
 Hylobates lar NAT2  
 Pongo pygmaeus NAT2
 Pan troglodytes NAT2     
 Pan paniscus NAT2 
 Gorilla gorilla NAT2 
























Figure 5 Evidence for lineage-specific positive selection in the primate NAT phylogeny. Branches with evidence of positive selection (ω > 1),
as estimated by the free-ratio model (branch-specific test), are shown with black thick lines and are labeled from a to e. The estimated ω ratio and
numbers of nonsynonymous and synonymous changes for each branch are as follows: a (∞; 8.1/0.0), b (∞; 5.1/0.0), c (∞; 7.0/0.0), d (1.07; 3.9/1.3), e (1.63;
4.5/1.0). In addition, branch-site tests were carried out to test for positive selection in 9 pre-specified lineages (highlighted in red): the ‘B’ letter refers to
the branch-site tests performed at the branch level and the ‘C’ letter refers to those performed at the clade level (multiple branch-site analysis, see
Methods). *Statistically significant branch-site tests at the conventional P-value threshold of 0.05 (not corrected for multiple testing). **Statistically
significant branch-site tests at the Bonferroni-corrected threshold of 0.0056 (9 tests).
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also identified as positively selected with PP ranging from
77% to 87% in the three NAT2 clades pointed out by mul-
tiple branch-site analysis (C7, C8 and C9, Figure 5). Codon
site 129, which plays a key role in determining NAT2 sub-
strate selectivity, was identified with lower confidence
(PP ≥ 90%). Although the free-ratio model was not a better
fit to the data than a single ω ratio for the entire NAT2
phylogeny (2ΔlnL = 27.52, P > 0.05), some branches did
exhibit ω > 1 (branches c, d and e; Figure 5).
Variation of selective pressures along the NAT protein
sequence
The three-dimensional crystal structure of NAT isoen-
zymes has been resolved for several organisms, enablinga thorough evaluation of structure-function relationships
without the limitations inherent to molecular homology
modeling [5]. The fold of human NAT1 and NAT2 pro-
teins largely resembles the overall structure of their pro-
karyotic orthologs, traditionally described as composed
of three domains, each of which being approximately
equal in length [27] (Figure 6). The first domain is pre-
dominantly α-helical, the second domain mainly consists
of β-strands and the third domain is a α/β lid. The first
two domains, which have been implicated in active-site
pocket formation and acetyl-CoA binding, are connected
to the third domain through the α-helical interdomain.
The third domain has been associated with acetyl-
acceptor specificity [27,32]. In human NATs, residues



















































Figure 6 Variable selective pressures (ω) along NAT protein sequence. The posterior mean of ω was estimated for each of the 290 amino
acid residues by the codeml program (a) in the vertebrate dataset (n = 77 coding sequences), (b) in the mammalian dataset (n = 55 coding
sequences), (c) in the primate dataset (n = 43 coding sequences), (d) in the set of 19 simian NAT2 coding sequences. A graphical representation
of the three-domain structure of human NAT1 and NAT2 proteins is shown at the bottom. Residues 1–83 in the N-terminus form domain I,
mainly consisting of α-helices; residues 84–192 form domain II, mainly consisting of β-strands, followed by inter-domain comprising residues
193–229, and residues 230–290 consisting of both α-helix and β-strands form domain III. The amino and carboxyl termini are labeled as NT and
CT, respectively. The 17-residue insertion and carboxyl-terminal tail of human NATs, which are lacking in the structures of prokaryotic NATs, are
highlighted with thick lines. Residues of the catalytic triad are highlighted with stars, residues interacting with CoA are highlighted with black
triangles, and residues involved in substrate binding are highlighted with white triangles.
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located in domain II is associated with the domain III β-
sheet, apparently providing structural stability and limit-
ing active site access [33]. Also, the C-terminal tail is not
α-helical, as is the case for the bacterial NATs, but is in-
stead a coil that reaches around and associates with the
active site cleft, thereby playing a key role in defining
the size and shape of the active site pocket.
The well-known relationship between the primary
sequence of eukaryotic NATs and the structural and
functional features of these enzymes prompted us to
examine the variation of ω along the NAT protein se-
quence in the different datasets investigated: (i) the ver-
tebrate dataset, including the full set of 77 vertebratesequences as well as a subset of 55 mammalian se-
quences, and (ii) the primate dataset, including the full
set of 43 primate sequences as well as the subset of 19
simian NAT2 orthologous sequences. We looked at the
variation of the posterior mean of ω as estimated by the
codeml program under the site-specific model that best
fitted the data (Figure 6). Moreover, we tested for signifi-
cant differences in the mean ω value between different
parts of the protein (domain I, domain II, interdomain,
domain III, 17-residue insert, C-terminal tail) and differ-
ent sets of sites (residues involved either in CoA binding
or in substrate binding, Additional file 6: Table S2 and
Additional file 7: Table S3). Our results revealed a sig-
nificant heterogeneity of ω between the four protein
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III) in the four datasets analysed (Kruskal-Wallis P
values ≤ 0.03). More specifically, the first domain was
found to evolve under more selective constraints, with a
mean ω value being significantly lower than those ob-
served for domain II, domain III or the rest of the se-
quence (Mann-Whitney P < 0.05, Additional file 6: Table
S2 and Additional file 7: Table S3). By contrast, domains
II and III did not show any differences in their mean ω
value when compared to the rest of the sequence
(Mann-Whitney P > 0.05). These results were consist-
ently observed in the four datasets examined. Besides,
the interdomain region, 17-residue insert and C-
terminal tail were all found to evolve in vertebrates
under more relaxed selective constraints than the rest of
the sequence, as reflected by significantly higher ω values
(Mann-Whitney P = 0.03, P = 0.02, P = 0.007, respectively).
A similar finding was observed for the C-terminal tail in
the mammalian (P = 0.06), primate (P = 0.01) and simian
NAT2 (P = 0.03) datasets, consistent with the major role of
this region in determining arylamine substrate specificity.
Interestingly, the mean ω value of the set of sites in-
volved in CoA binding was strikingly high when com-
pared to the mean ω value at the global protein level in
vertebrates (0.70 vs. 0.34, Mann-Whitney P = 0.002),
mammals (0.77 vs. 0.40, P = 0.003) and primates (0.73 vs.
0.47, P = 0.011). Conversely, adaptive molecular evolution
was evidenced in the simian NAT2 dataset for those
sites involved in substrate binding compared to the full
set of sites in the protein (1.31 vs. 0.66, P = 0.044).
Discussion
The general role of NATs in the detoxification and meta-
bolic activation of aromatic amine xenobiotics, ranging
from dietary components to common environmental
toxins and pharmaceuticals, has been well documented
(reviewed in [34-36]). The possibility that the NAT en-
zymes could be broadening or changing their substrate
specificity in accordance to the high diversity of xenobi-
otics compounds environmentally available suggests that
their metabolic function could be under adaptive evolu-
tion and makes them a promising subject for evolution-
ary analyses. Numerous studies have indeed identified
the signature of different selective pressures in genes in-
volved in the metabolism of exogenous substances
[37-44]. However, in contrast to the evolutionary pro-
cesses affecting the NAT2 gene in humans, which have
been the subject of extensive research, little is known
about the role of molecular adaptation in the evolution
and diversification of the NAT gene family as a whole on
a longer evolutionary time scale.
The ongoing sequencing of entire genomes from vari-
ous organisms is providing unparalleled opportunity totrace the evolutionary history of the NAT gene family by
enabling the inference of the phylogenetic relationships
among NAT sequences over a wide range of taxa. Several
previous surveys of public genomic databases have re-
trieved NAT-like sequences and documented the distribu-
tion of NAT genes across all major clades of life [1,2,45].
The last survey by Glenn et al. [2] provided an exhaustive
annotation of NAT-homologous sequences recovered
through inspection of 2445 genomes encompassing all
major taxa from bacteria and archaea to protists and fungi,
to animals. The same investigators also performed phylo-
genetic analyses of the retrieved NAT-homologous protein
sequences, providing a broad perspective of NAT evolu-
tion. Another study, focusing specifically on the phylogeny
of NATs in fungi, has also been published since then [3].
In the present study, we expanded the previous survey by
Glenn et al. [2] by performing a comprehensive search of
NAT-like sequences in the genomes of vertebrate species
and compiled an up-to-date dataset of 77 vertebrate NAT
sequences from 38 distinct species, among which 26 were
identified for the first time (Figure 1). In contrast to the
previous dataset of 55 vertebrate sequences in Glenn et al.
[2], we decided to exclude one lizard and three fish se-
quences from analysis (Anolis carolinensis NAT3, Oryzias
latipes NAT3, Fugu rubripes NAT1, Tetraodon nigroviridis
NAT1) because they aligned poorly with other vertebrate
NATs and introduced too many gaps and alignment ambi-
guities. The deduced protein sequence of these four genes
clustered together in a monophyletic clade with three in-
vertebrate NAT protein sequences at the basal position of
the vertebrate NAT phylogeny reconstructed by Glenn
et al. [2]. The authors suspected the possibility that this
clustering might be an artifact stemming from long branch
attraction, supporting our decision to exclude these par-
ticular sequences from our phylogenetic analysis of verte-
brate NAT genes. It is also important to note that, because
the vertebrate genomes we considered are in various
stages of draft sequencing, assembly, and annotation, we
cannot exclude that the present survey missed additional
extant NAT sequences. This warrants some caution in the
conclusions that may be drawn from the present phylo-
genetic analysis. The increased availability of genome se-
quence data from diversified taxa is likely to continue to
improve our understanding of the evolutionary history of
the NAT gene family in vertebrates.
Our phylogenetic analysis of vertebrate NAT sequences
nevertheless demonstrated that the NAT gene family has
evolved under a dynamic process called birth-and-death
evolution. This process, which operates through three
major mechanisms - neofunctionalization, subfunctiona-
lization, and pseudogenization, is thought to be an import-
ant source of genetic diversity and evolutionary change that
affords functional diversification over short timescales
[46]. Our results are in accordance with the previous
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that function as xenobiotic detoxifiers are often phylogenet-
ically unstable genes that undergo rapid birth-and-death
evolution, possibly in response to changing environmental
conditions. It is noteworthy that Martins et al. [3] found
similar patterns of gain and loss in fungi, arguing for a com-
plex dynamics of these genes in a broader range of
organisms.
Concerted evolution via interlocus gene conversion is
increasingly recognized as a major feature of evolution
in small multigene families (e.g., [37,47-49]). By homo-
geneizing the sequence of paralogous gene copies, the
converted paralogs may come to resemble one another
more than they do to orthologous sequences in other
species. Therefore, gene conversion may potentially alter
the relationships among paralogs and lead to the conclu-
sion of independent duplications instead of multiple
gene conversions in multiple species. The work carried
on the CYP1A1 subfamily [37] provides a good example
of how gene conversion can obfuscate gene orthology
relationships and lead to incorrect conclusions when
based solely on the results of traditional phylogenetic
analyses. However, identification of gene conversion
events remains a challenging task as the methods com-
monly employed for detecting such events can have a high
false-negative rate, particularly when gene conversion is
frequent and covers a large portion of the duplicates [50].
It is thus advocated to consider the occurrence of gene
conversion using various recombination detection algo-
rithms and to combine information coming from both
phylogenetic analysis and fine-scale synteny maps. We
have used six different methods to evidence possible re-
combination events between paralogous pairs. Only four
events, each involving a NAT1-NAT2 pair, were detected
by at least two methods (one each in the fish Oryzias
latipes and rat Rattus norvegicus, and two in the bat My-
otis lucifugus, Table 1), thus suggesting that concerted evo-
lution has played only a minor role in the diversification
of the vertebrate NAT gene family. This conclusion is fur-
ther supported by: (i) the identical phylogenetic relation-
ships inferred from NAT sequences of which the regions
putatively involved in gene conversion events were trun-
cated (Additional file 2: Figure S1), and (ii) the fine-scale
synteny comparisons between the three avian species ana-
lyzed (Figure 2), as well as between human and mouse
(Additional file 3: Figure S2), which evidenced multiple
gene duplications events occurring independently in spe-
cific lineages. Thus, our analysis of vertebrate NAT se-
quence data suggests that gene conversion is unlikely to
have played a major role in the patterns of divergence of
NAT sequences and rather supports a scenario of multiple
independent gene duplications.
In humans, there are two NAT isoenzymes encoded at
two polymorphic loci. NAT2 polymorphisms modifyindividual cancer risk and drug response, or susceptibil-
ity to adverse drug reactions [15,16,51]. Although less
well-established, human NAT1 also exhibits genetic
polymorphism and several-albeit as yet inconclusive-
studies have suggested that variant NAT1 genotypes are
associated with susceptibility to a number of diseases in-
cluding various cancers [15] and birth defects [52-56].
Given their high level of polymorphism and their associ-
ation with variable responses to environmental toxins
and drugs, these genes are good candidates to test for
positive selection and several studies have investigated
the possible role of natural selection in shaping genetic
variation at these loci (e.g., [17,23] etc.). Besides their
role in phase II metabolism of xenobiotics, several stud-
ies have explored the possible endogenous roles of these
enzymes. While no endogenous substrate has been iden-
tified to date for NAT2, several lines of evidence support
the role of human NAT1 in folate catabolism, thereby
providing an explanation for its postulated association
with congenital defects linked to a disruption in folate
metabolism [6]. The widespread tissue distribution of
NAT1 and its early expression in development further
support a physiological role of this enzyme which might
be essential to normal embryonic development (see [10]
for review). Therefore, since NAT1 and NAT2 appear to
have distinct functional roles in humans, it is worthwhile
to investigate whether these genes have experienced dif-
ferent selective regimes throughout evolution. The iden-
tification of the true orthologous sequences to human
NAT1 and human NAT2 in Simiiformes and their deter-
mination in 13 additional simian species (Figure 4) pro-
vided us the necessary power to enable a separate
analysis of the two sets of sequences and evaluate the
changes in selective pressures experienced by the two
gene copies after their functional divergence. Interest-
ingly, two distinct evolutionary patterns emerged for the
two paralogs (Table 3). Our analysis suggested a domin-
ant role of purifying selection in NAT1 protein evolu-
tion, acting for a conservation of biochemical functions
which is in agreement with the role of NAT1 in en-
dogenous metabolism and homeostasis. Note, however,
that a signal of positive selection was detected in the hu-
man lineage for this gene and that the pattern of evolu-
tion of NAT1 is likely to be mosaic with some evidence
of positive selection in certain lineages (in humans but
maybe also in several other species not included in the
present analysis). By contrast, in most of the species in-
vestigated, NAT2 was predicted to evolve under diversi-
fying selection to change its amino acid sequence over
time, probably in response to changes in xenobiotic ex-
posure. This finding is consistent with the observations
made at a population level within the human species by
previously published studies which supported an adap-
tive evolution of the NAT2 gene through either balancing
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low level of polymorphism reported at NAT1 within the
human species [17,23] is consistent with the action of
purifying selection evidenced at the interspecies level in
the present study. Evolutionary analyses thus strongly sup-
port a differential role of the two isoenzymes and the in-
volvement of NAT1 in endogenous metabolic pathways.
Although the folate catabolite pABG is the only endogen-
ous substrate identified to date, one cannot dismiss the
possibility that other as yet unknown endogenous sub-
strates and physiological roles may exist for NAT1.
Besides an evaluation of the selective forces acting on
members of the NAT gene family, our ML-based phylo-
genetic analysis allowed us to estimate the strength of nat-
ural selection acting at a codon level and to shed light on
episodes of adaptive evolution at specific sites and do-
mains of the protein. Several amino acid sites were pre-
dicted to be under positive selection with high PP (PP ≥
95%) throughout vertebrate evolution: codons 97, 98, 104,
214, 286. Interestingly, four of these codon positions were
shown to be involved in CoA binding according to the re-
cent structural studies performed on human NAT1 and
NAT2 isoenzymes [27]. The residues 97P and 98 V are in-
volved in hydrophobic interactions with the adenine ring
of CoA, whereas the amide nitrogen of residue 104 G and
the hydroxyl group of 214 T form hydrogen bonds with
the pyrophosphate group of CoA. It is noteworthy that the
fifth codon position predicted to be under adaptive evolu-
tion is the site of a well-known polymorphism in the hu-
man NAT2 protein: G286E (c.857 G > A), which defines
the NAT2*7 slow haplotype series, is one of the four major
nonsynonymous substitutions encountered in human pop-
ulations and is particularly common in Asia [24]. Func-
tional studies of the G286E variant in mammalian cells
demonstrated reduced affinity to both substrate and cofac-
tor acetyl-CoA, resulting in reduced catalytic activity to-
wards some substrates (such as sulfamethazine and
dapsone) but not others (such as 2-aminofluorene and iso-
niazid) [57]. Codon 286 is located on the C-terminal tail
in the third domain directly adjacent to the active site. Be-
cause the C-terminal tail has an important role in defining
the size and shape of the active site cavity, a significant
amino acid change at this position is likely to alter active
site access and substrate selectivity, which is consistent
with the substrate-dependent activity changes observed
experimentally for the G286 variant. Such a significant
change to a C-terminal residue adjacent to the active site
is also likely to affect acetyl-CoA binding and 68C acetyl-
ation [58]. Note that the branch-site tests identified four
additional sites (11, 100, 102 and 272) as having evolved
under positive selection along particular lineages of the
vertebrate phylogeny or in a specific clade (B4, B12 and
C2, Figure 3). Interestingly, codon 102 is also known to be
involved in CoA binding and codon 272 is located in theC-terminus region of the protein. Moreover, two codon
sites (173 and 191) were pinpointed to be under diversify-
ing selection throughout simian NAT2 evolution. While
the functional and/or structural significance of these two
codons have not yet been explored, they are likely to be
important in the function of the NAT2 protein and further
investigations are warranted to define their potential rele-
vance. In contrast to these positively selected codons, very
low values of ω, suggesting rather strong functional con-
straints, were observed for the three sites of the catalytic
triad: 0.054, 0.051 and 0.050 for Cys68, His107, Asp122,
respectively, in the vertebrate dataset. These three sites
were all conserved in the entire set of NAT coding se-
quences considered, thereby confirming the importance of
these three residues in the activation of the active site cyst-
eine residue. Interestingly, domain I was found to be more
constrained than the other domains of the protein, con-
sistent with the lower variability displayed by this region
(mean Shannon entropy (H) = 0.70) as compared to do-
main II (H = 0.84) and domain III (H = 0.93). Conversely,
higher ω values were observed for the interdomain, 17-
residue insert and C-terminus regions of the protein. In
particular, the C-terminal tail was shown to evolve under
more relaxed selective constraints in the four datasets ex-
amined and many sites pinpointed to be under adaptive
evolution were located in this region. This is consistent
with the association of this region with different acetyl-
CoA binding properties and substrate specificities.
Conclusions
In this study, we provided unequivocal evidence that the
NAT gene family has undergone a complex history of du-
plications and possibly gene losses, as observed for many
multigene families encoding xenobiotic-metabolizing en-
zymes (e.g., [39-41,43]). We also found evidence of posi-
tive selection for amino acid change in the NAT protein
sequence in many lineages throughout vertebrate evolu-
tion, suggesting that diversification of the NAT gene family
is achieved by a combination of gene duplication and
selection-driven divergence in sequence. By then focusing
on the evolution of this family in primates, we revealed
different selective regimes for the two primate paralogs
NAT1 and NAT2, consistent with a differential role of the
two isoenzymes. Our evolutionary analyses strongly sup-
port the key role of the C-terminal region which should be
a primary focus of future functional studies.
Methods
Collection of vertebrate NAT sequences from genomic
databases
All available vertebrate genomes in various stages of draft
sequencing, assembly, and annotation were searched
for the presence of putative NAT genes by TBLA-
STN searches in the National Center for Biotechnology
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(http://www.ensembl.org) databases, using the protein
sequence of human NAT1 as the query and an E-value
cut-off of 10-5. Once we identified the first set of verte-
brate sequences using the human probe, subsequent
searches were conducted by using the sequences of repre-
sentative species within a given taxonomic class or order
to identify additional sequences in the same group of taxa.
More specific searches were also performed using the
NAT protein-coding sequence identified in one organism
to look for additional NAT paralogs in its genome. We
discarded sequences with more than 200 missing nucleo-
tides and only sequences with an identified ORF were kept
in the final data set. Sequences from the Syrian hams-
ter (Mesocricetus auratus) and the Chinese hamster
(Cricetulus griseus) were obtained from GenBank (acces-
sion numbers: U05271 Mesocricetus auratus Nat1, L24912
Mesocricetus auratus Nat2, NM_001244413 Cricetulus
griseus Nat2). Fine-scale synteny data around the NAT
genes locus were retrieved from Genomicus v63.01 [59]
and the UCSC genome browser [60].
To name the NAT sequences identified in vertebrate
species, we followed the official gene nomenclature for
non-human NAT genes in eukaryotes and prokaryotes
(http://mbg.duth.gr/non-humannatnomenclature/): names
were given according to the descending identity between
each reported NAT sequence and human NAT1. The
symbol NAT1 was thus assigned either to the NAT se-
quence demonstrating the highest identity to human
NAT1 or to the only NAT gene found in a specific genome.
In rodents, the nomenclature followed the consensus for
mouse Nat genes, with rodent Nat2 representing the se-
quence bearing higher identity to human NAT1 and ro-
dent Nat1 being more similar to human NAT2.
Amplification, cloning and sequencing of NATs in primates
Based on available DNAs, we selected a representative
number of primate specimens belonging to 13 distinct
genera, including 3 hominoids, 8 Old World monkeys
and 2 New World monkeys, for which the NAT homolo-
gous sequences were determined: Pan paniscus (bo-
nobo), Hylobates lar (white-handed gibbon), Nomascus
gabriellae (yellow-cheeked gibbon, Macaca sylvanus
(barbary macaque), Mandrillus sphinx (mandrill), Cerco-
pithecus diana (diana monkey), Chlorocebus tantalus
(tantalus monkey), Erythrocebus patas (patas monkey),
Allenopithecus nigroviridis (allen’s swamp monkey),
Colobus guereza (guereza), Presbytis cristatus (silvered-
leaf monkey), Pithecia pithecia (white-faced saki), and
Cebus apella (tufted capuchin).
We designed amplification primers based on conserved
sequences in the multiple alignments of database se-
quences retrieved from the genomes of Homo sapiens,
Pan troglodytes, Gorilla gorilla, Pongo pygmaeus, Macacamulatta, and Papio hamadryas. Separate alignments for
sequences homologous to human NAT1, NAT2 and NATP
were as considered. Each newly obtained sequence was
added to the alignments to refine primer specificity. The
list of all primers used in the present study is provided in
Additional file 8: Table S4. PCR reactions were carried out
in 25 μl final volume, containing 25 ng of genomic DNA,
10 mM of each primer, 7.5 mM MgCl2, 2.5 mM dNTP
mix, 1U GoTaqW DNA polymerase (Promega), and H2O.
PCR conditions were as follows: denaturation at 95°C for
10 min, followed by 38 cycles at 94°C for 1 min (denatur-
ation), 55°C for 50 s (annealing temperature-variable de-
pending on the set of primers used, see Additional file 9:
Table S5) and 72°C for 2 min (elongation), with a final
10 min elongation step at 72°C. Depending on the primate
species, different primer pairs and annealing temperatures
were used to optimize PCR conditions (Additional file 6:
Table S2). PCR products were purified from agarose gels
with the QIAquick Gel extraction kit and were sequenced
in both directions by Millegen company (Labège-France)
on an ABI 3730XL capillary sequencer (Applied Biosys-
tems). In the case of non-specific amplifications, PCR prod-
ucts were cloned using the pGEMW-T Easy Vector System
(Promega), according to manufacturer’s instructions, and
both strands of the cloned fragments were sequenced using
the M13F and M13R universal primers.
Protein and codon sequence alignments
After discarding a few very divergent sequences that
aligned poorly (Anolis carolinensis NAT3, Oryzias latipes
NAT3, Fugu rubripes NAT1, Tetraodon nigroviridis
NAT1), the remaining set of NAT ORF sequences were
translated using the ExPASy Translate tool (http://web.
expasy.org/translate/) and the amino acid sequences
were aligned using ClustalW [61] and Multalin [62].
Both programs yielded similar results. The amino acid
alignments were then converted to the corresponding
alignments of codons using the PAL2NAL program [63].
These nucleotide alignments were used as inputs for the
construction of phylogenetic trees, the analysis of gene
conversion and tests of positive selection.
Phylogenetic analysis
Phylogenetic trees were built from two nucleotide align-
ments: the first one included the 77 vertebrate NAT se-
quences retrieved from genomic databases (referred to as
the ‘vertebrate dataset’) and the second one was composed
of 58 primate sequences, including both the 17 database
sequences and the 41 newly generated ones (referred to as
the ‘primate dataset’). Phylogenetic relationships of NAT
sequences were reconstructed using the maximum likeli-
hood method implemented in PhyML v2.4.4 [64], after de-
termining the optimal model of sequence substitution
with Modeltest 3.04 [65]. For both datasets, a general time
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gamma distributed among-site rate variation (GTR + I +G)
was used, as selected by the Akaike information criterion.
The initial tree was determined by neighbor-joining
(BIONJ). Branch supports were estimated from 1,000
PhyML bootstrap replicates using the same settings. Trees
were displayed and colored with Bonsai 1.2 (http://depts.
washington.edu/jtlab/software/softwareIndex.html).
Detection of gene conversion
Possible recombination and gene conversion events were
detected using GeneConv version 1.18 [66,67]. The pro-
gram tests for gene conversion by finding identical frag-
ments between pairs of sequences in a nucleotide
alignment. Global and pairwise P-values are calculated
in order to assess the statistical significance of the ob-
served fragment lengths. Global P-values are more con-
servative because they are based on the comparison of
each fragment with all possible fragments for the entire
alignment. GeneConv was run using a group structure
defining a distinct group for each set of NAT coding se-
quences within a species so as to look only for within-
species gene conversion events and adjust Bonferroni
corrections accordingly. All the default settings were
used except for the mismatch penalty (set to 2) and the
number of random permutations to compute global and
pairwise P-values (set to 1,000,000). Only gene conver-
sion events with global permutation P-values ≤ 0.01 were
retained. In order to avoid confounding effects due to
strong selection or recent mutation, GeneConv was also
run using only silent sites.
Intragenic recombination events were also detected
using five other methods implemented in the RDP3
v.3.44 software package [68]: two of these are phylogen-
etic methods, which infer recombination when different
parts of the genome result in discordant topologies
(RDP [69] and Bootscan [70]), while the other three are
nucleotide substitution methods, which examine the se-
quences either for a significant clustering of substitu-
tions or for a fit to an expected statistical distribution:
MaxChi [71], Chimaera [72], and SiScan [73]. Common
settings for all methods were to consider sequences
as linear, to require phylogenetic evidence, to polish
breakpoints and to check alignment consistency. RDP
was run with default settings modified to use internal
and external reference sequences and a window size of
30 bp. Default settings were used for MaxChi and Chi-
maera analyses. Bootscan default settings were modified
to perform 1000 bootstrap replicates with cutoff per-
centage set to 95%. SiScan was run using a window size
of 200 bp and a step size of 50 bp. P-values from indi-
vidual algorithms were Bonferroni corrected to account
for both multiple testing within each method and for
multiple tests by different methods. Only events withcorrected P-values < 0.01 were considered and the
detected events were filtered to eliminate predictions of
interspecies recombination.
Maximum likelihood tests of positive selection
The ratio of nonsynonymous (amino acid altering) to
synonymous (silent) substitution rates (dN/dS or ω) was
used to evaluate the selective pressures acting on the
NAT coding region, expecting dN/dS = 1 for neutrality,
dN/dS < 1 for purifying selection, and dN/dS >1 for posi-
tive selection. The analysis was performed using the
codeml tool of the PAML package version 4.2b [26,74],
which allows pairs of nested models with and without
positive selection to be tested in a likelihood ratio frame-
work to determine if adaptive evolution has occurred.
We used two pairs of site-evolution models to test
whether some sites (codons) are under positive selection:
(1) the M1a (Nearly Neutral) and M2a (Positive Selec-
tion) models and (2) the M7 (beta) and M8 models (beta
& ω). M1a allows sites to fall into two categories with
ω < 1 (purifying selection) and ω = 1 (neutral evolution),
whereas model M2a extends model M1a with a further
class with ω > 1 (positive selection) [75,76]. M7 allows
ten classes of ω sites between 0 and 1 according to a
beta distribution with parameters p and q, whereas M8
adds an additional class with ω possibly > 1 as M2a does.
Candidate sites for positive selection were pinpointed
using the BEB approach described by Yang et al. [77],
which calculates the posterior probability that each
codon site falls into a site class affected by positive selec-
tion (in models M2a and M8) and provides the posterior
ω values which represent the strength of natural selec-
tion acting on each residue. The heterogeneity of the
dN/dS ratio among lineages (branch-based test) was
tested by comparing the free-ratio model, which assumes
as many ω parameters as the number of branches in the
tree, to the one-ratio null model M0 which assumes only
one ω value for all branches [78]. Finally, we used the
branch-site test of selection developed by Zhang et al.
[79] to detect episodic positive selection along pre-
specified lineages on a phylogeny that affects only a few
sites in the protein-coding gene. By focusing on individ-
ual amino acid residues and particular lineages, this test
should provide greater power than site-based tests,
which average substitution rates over all branches on the
phylogeny, or branch-based tests, which average over all
codons in the gene [79-81]. In this test, the branch being
tested for positive selection is called the foreground
branch, and the other branches in the tree are called the
background branches. In the null model, all codons in
the foreground and background branches are assumed
to evolve under negative selection (ω < 1) or neutrally
(ω = 1), whereas in the alternative model A, the fore-
ground branch also includes sites evolving under positive
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ability that each site falls into the positively selected class
was calculated using the BEB method. Branch-site tests
were also carried out at the clade level by performing a
multiple branch site analysis where all the branches
within a clade are grouped as the foreground lineage and
the remaining branches in the tree are grouped as back-
ground [82]. This approach allows testing adaptive evolu-
tion in multiple branches while avoiding the assumptions
of the clades analysis model (CmC, [83]) which has been
shown to have a high false-positive rate and to be highly
unreliable when faced with moderate among-site ω vari-
ation [84].
In all PAML analyses, model comparisons were made
using LRTs. For each of the LRTs, twice the log-
likelihood difference between alternative and null model
(2ΔlnL) was compared to critical values from a χ2 distri-
bution with degrees of freedom equal to the difference
in the number of estimated parameters between both
models [75]. In branch-site tests, we used the conserva-
tive X21 distribution to conduct the LRT and the
Bonferroni correction was employed to control the type I
error rate when comparing multiple foreground lineages.
To avoid local optima and ensure that the global peak is
found, each model was run three times with different
ω starting values. The three runs always produced identi-
cal results. To identify codon sites under positive selection
along specific branches of particular interest, we infer-
red ancestral sequences using baseml (model = HKY85,
Mgene = 4; cleandata = 0) and identified nonsynonymous
changes by pairwise comparison of sequences. In all
PAML analyses, codons containing alignment gaps due to
insertion-deletion events among species were treated as
missing data and not considered in pairwise comparisons
where one species contained sequence and another species
did not. We used the F3 × 4 codon model of Goldman and
Yang [85] which is very similar to the nucleotide model
HKY85 with different substitution rates and base frequen-
cies for the three codon positions. The analyses were ap-
plied to several different partitions of the data, as
described in the Results section.
Additional files
Additional file 1: Alignment result for the set of 77 vertebrate NAT
nucleotide sequences.
Additional file 2: Figure S1. Maximum likelihood tree of vertebrate
NATs obtained using PhyML after removing all regions affected by gene
conversion from the multiple nucleotide alignment (converted fragments
were replaced by ‘?’ characters in the alignment). A general time
reversible model with a proportion of invariant sites and gamma
distributed among-site rate variation (GTR + I + G) was used, as selected
by Akaike information criterion in Modeltest 3.04. The tree is rooted with
the three fish species (Danio rerio, Gasterosteus aculeatus, Oryzias latipes)
and bootstrap values of 1,000 replicates are shown as percentages at
nodes. Bootstrap values are only shown for nodes with greater than 50%support. The clades of Afrotheria, Laurasiatheria, Lagomorpha, Rodentia
and Primates are shown in aqua blue, purple, green, blue and red,
respectively.
Additional file 3: Figure S2. Gene order and orientation in regions
surrounding the NAT genes on human (Homo sapiens) and mouse (Mus
musculus) chromosome 8. Gene lengths and intergenic distances are not
drawn to scale. Double slashes (//) indicate continuing sequence data
extending toward the centromeric (cen) and telomeric (tel) parts of the
chromosome. Grey boxes indicate NAT-like sequences. The region
encompassing the three NAT loci spans approximately 190 kb in human,
but less than 60 kb in mouse. In humans, two of the loci are functional
(NAT1 and NAT2) and one is a pseudogene (NATP). In mice, all three
appear to generate functional transcripts, although no apparent specific
substrate for the product of the third locus (Nat3) has been identified.
Interestingly, Mouse Nat2 is considered as the functional equivalent of
human NAT1, based on substrate profile, tissue distribution and
expression during development (see [10] for review).
Additional file 4: Table S1. Patterns of nucleotide substitutions along
the four branches showing evidence of positive selection in the Pteropus
vampyrus clade of NAT genes.
Additional file 5: Alignment result for the set of 58 primate NAT
nucleotide sequences.
Additional file 6: Table S2. Posterior mean of ω as estimated by the
codeml program for different regions and different categories of sites in
the NAT protein for the four datasets investigated.
Additional file 7: Table S3. Comparisons of the mean ω between
different regions and categories of sites within the NAT protein sequence.
Additional file 8: Table S4. Primers for amplification and sequencing
of primate NAT genes.
Additional file 9: Table S5. Primer pairs and annealing temperatures used
for each primate species for the PCR amplification of the three NAT genes.
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